Daxor Corp. (DXR) Anemia Diagnostic Test Results featured in Congestive Heart Failure Publication

QualityStocks would like to highlight Daxor Corporation (AMEX: DXR), a medical instrumentation and biotechnology company. Daxor manufactures and markets the BVA-100, the only FDA-approved semi-automated Blood Volume Analyzer. The BVA-100 is used in conjunction with Volumex, Daxor's single use diagnostic kit.

In the company’s news Friday,

Daxor Crop. announced the publication of a research article titled “Blood Volume Measurements in Patients with Heart Failure and a Preserved Ejection Fraction: Implications for Diagnosing Anemia” in the journal Congestive Heart Failure, which highlights a study using Daxor’s Volume Analyzer (BVA-100).

Anemia, or low red blood cell count, is often found in patients with Heart Failure and Preserved Ejection Fraction (HFPEF). Anemia is traditionally diagnosed by measuring hemoglobin levels in a standard blood test, though patients with heart failure are harder to diagnose because of blood volume distortions, which can lead to overdiagnosis.

Daxor’s BVA-100 precisely measured the red blood cell volume in 60 patients with heart failure and a preserved ejection fraction. The results were compared to ideal red blood cell volume for each patient as measured by the standard method of diagnosing anemia based on hemoglobin levels.

The study showed considerable differences between the two methods: anemia defined by the standard hemoglobin test was present in 67 percent of subjects, and did not differ based on gender or race. In comparison, using direct blood volume measurement to diagnose anemia, anemia was found in only 35 percent of patients.

The results indicate that with the standard hemoglobin blood testing, there was a doubled increase in overdiagnosis in the studied patient population. Misdiagnosing anemia can lead to an elevated red blood cell count, which could lead to stroke or other medical conditions.

The published research article can be viewed on Daxor’s Website at www.daxor.com/pdfs/CHFVol17Iss1-Noumi-Blood-Volume-Measurements.pdf

About QualityStocks

QualityStocks, based in Scottsdale, Arizona, is a free service that collects data from hundreds of Small-Cap and Micro-Cap online Investment Newsletters into one Daily Newsletter Report. QualityStocks is dedicated to assisting emerging public companies with their investor communication efforts and connecting subscribers with companies that have huge potential to succeed in the short and long-term future.

To sign up for “The QualityStocks Daily Newsletter” please visit www.QualityStocks.net

Please see disclaimer on QualityStocks website: http://Disclaimer.QualityStocks.net

Forward-Looking Statement:

This release may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All forward-looking statements are inherently uncertain as they are based on current expectations and assumptions concerning future events or future performance of the company. Readers are cautioned not to place undue reliance on these forward-looking statements, which are only predictions and speak only as of the date hereof. Risks and uncertainties applicable to the company and its business could cause the company's actual results to differ materially from those indicated in any forward-looking statements.